Congratulations to Dr. Don Sheppard who obtained a CIHR Foundation Grant ($2,270,367) for his project titled "Human Fungal Infections - Targeting host-pathogen interactions to develop novel antifungal therapies".

In total, only 36 projects were funded across Canada and 12 in Quebec (More information on the CIHR website). 

Summary of the project:

Fungal infections are common and devastating in patients whose immune systems do not work properly or those with long-term lung disease. Our research program seeks to understand at a molecular level how molds and other fungi can cause human disease. We have identified two types of sugars made by fungi such as the mold Aspergillus that allow them to attach to human tissues and invade our lungs. We have developed new therapies that target these sugars in order to develop new therapies to treat or prevent these infections. These therapies include proteins that can be used to break down these sugars during infection, and vaccines that boost the response of our immune system against fungi. These strategies have already shown promise in animal studies. In the coming years we will refine and optimize these therapies and continue our discovery research to identify new sugar molecules that fungi use to cause human disease. Identifying these new sugars will provide us with new targets for our antifungal development pipeline. These studies will both improve our understanding of how fungi cause human disease, and provide us with new weapons in the fight against these devastating infections.

IDIGH Calendar

<<  <  March 2018  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
     1  2  3  4
  5  6  8  91011
121315161718
192022232425
2627293031 

Upcoming Events

Latest IDIGH Publications

  1. Saroli Palumbo, C., Bessissow, T. & Sebastiani, G.
    (2019)
    .
    Reply to "Transient Elastography in IBD Patients"
    .
    Inflammatory bowel diseases
  2. Fakih, I., Fortin, É., Smith, M.-A., Carignan, A., Tremblay, C., Villeneuve, J., Moisan, D., Frenette, C., Quach, C., Schmidt, A. M. & for SPIN-BACTOT.
    (2019)
    .
    Healthcare-associated bloodstream infection trends under a provincial surveillance program
    .
    Infection control and hospital epidemiology
    ,
    vol
    .
    40
    ,
    p
    .
    307-313
    .
  3. Rossi, C., Young, J., Martel-Laferrière, V., Walmsley, S., Cooper, C., Wong, A., Gill, M. J., Klein, M. B. & Canadian Co-Infection Cohort Investigators .
    (2019)
    .
    Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical Care
    .
    Open forum infectious diseases
    ,
    vol
    .
    6
    ,
    p
    .
    ofz055
    .
  4. Huang, J., Ma, Z., Zhong, G., Sheppard, D. C., Lu, L. & Zhang, S.
    (2019)
    .
    The mitochondrial thiamine pyrophosphate transporter TptA promotes adaptation to low iron conditions and virulence in fungal pathogen Aspergillus fumigatus
    .
    Virulence
  5. Mehraj, V., Ramendra, R., Isnard, S., Dupuy, F. P., Ponte, R., Chen, J., Kema, I., Jenabian, M.-A., Costiniuk, C., Lebouché, B., Thomas, R., Coté, P., Leblanc, R., Baril, J.-G., Durand, M., Chartrand-Lefebvre, C., Tremblay, C., Ancuta, P., Bernard, N. F., Sheppard, D. C., Routy, J.-P. & Montreal Primary HIV-infection Study and Canadian HIV and Aging Cohort Study Groups.
    (2019)
    .
    Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection
    .
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
More publications